rediff.com
India As It Happens
India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
rediff News App
Hi Guest
About 356 results for "continuous renal replacement therapy"
Nutritional and Metabolic Alterations during Continuous Renal ...Wiesen P, Van Overmeire L, Delanaye P, Dubois B, Preiser JC: Nutrition disorders during acute renal failure and renal replacement therapy. J Parenter Enteral Nutr 2011;35:217-222. Leverve X, Cano NJM: Nutritional Management in Acute Illness and ... Sexual Development, 2 weeks ago
Serum Cystatin C is Associated with Renal Function Recovery in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
- Sexual Development, 4 weeks ago
Continuous Renal-Replacement Therapy for Acute Kidney Injury
- New England Journal of Medicine, 2 months ago
|
5 images for continuous renal replacement therapy | ||||
Devices on cusp: Renal denervation, valves, stentsRenal denervation systems, percutaneous aortic valve replacement technologies and bioabsorbable coronary stents lead the pack for innovative cardiovascular devices in Novation's spring 2013 CV Watch report. Each of these emerging technologies has a ... Cardiovascular Business, 2 months ago
|
4 Traders
|
Rockwell Medical Closes $40.3 Million Public Offering of Common Stock) - Rockwell Medical, Inc. (NASDAQ: RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron deficiency, secondary ... BioMedReports, 4 days ago
Rockwell Medical Presents PRIME Study Results at the 50th ERA-EDTA Meeting in Istanbul, Turkey
Individual.com, 4 days ago
Rockwell Medical Announces the Exercise of Over-Allotment Option
Individual.com, 1 week ago
Rockwell Medical Announces Proposed Public Offering of Common Stock
Individual.com, 1 week ago
More from: StockHouse USA, CNBC...and 35 other sources
|
Corporate Information, Status of Operations and Management Plans(Edgar Glimpses Via Acquire Media NewsEdge) Amicus Therapeutics, Inc. (the Company) was incorporated on February 4, 2002 in Delaware and is a biopharmaceutical company focused on the discovery, development and commercialization of next-generation ... TMC Net, 2 weeks ago
|
Diaverum appoints Head of Quality & Business ProcessesDiaverum, one of the world's leading renal care providers, is aligning its organisational structure to respond to the strong growth of the company. Beatriz Bottner has joined Diaverum as Chief Quality & Business Processes Officer. She is a member of ... TMC Net, 2 weeks ago
Diaverum increases its clinic network with major acquisition of the Alte Teichweg clinics in Hamburg, Germany
Street Insider, 1 month ago
|
4 Traders
|
Amicus Therapeutics Announces First Quarter 2013 Financial Results and Corporate Updates12-Month Results From Ongoing Phase 3 Fabry Disease Monotherapy Study Anticipated 3Q13 Phase 2b Pompe Co-Administration Study on Track to Begin 3Q13 CRANBURY, N.J., May 9, 2013 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a ... BizWire Express, 2 weeks ago
AMICUS THERAPEUTICS, INC.: Amicus Therapeutics Announces First Quarter 2013 Financial Results and Corporate Updates
4 Traders, 2 weeks ago
AMAG Announces First Quarter 2013 Financial Results
Individual.com, 1 month ago
More from: , Pharmacy Choice...and 1 other sources
|
Cornerstone Therapeutics Acquires Exclusive U.S. Marketing Rights to PERTZYE(R) (pancrelipase) for TCornerstone Therapeutics Inc. (NASDAQ: CRTX), a specialty pharmaceutical company focused on commercializing products for the hospital and adjacent specialty markets, today announced it has entered into an agreement with Digestive Care, Inc. (DCI) to ... Interest!ALERT, 2 weeks ago
Cornerstone Therapeutics Inc. Acquires Exclusive U.S. Marketing Rights to PERTZYE® (pancrelipase) for Treatment of Exocrine Pancreatic Insufficiency in Patients With Cystic Fibrosis
BioSpace, 2 weeks ago
|
Islet Sciences Issues Shareholder Update LetterIslet Sciences, Inc., (ISLT) a clinical stage company engaged in the research, development and commercialization of therapeutics in the field of diabetes, issued the following shareholder update letter. Islet Sciences continues to put in place a ... Scottrade, 1 month ago
ISLET SCIENCES INC: Islet Sciences Issues Shareholder Update Letter
4 Traders, 1 month ago
More from: , Street Insider...and 5 other sources
|
EuroPCR 2013: Medtronic, St. Jude to build case for renal denervationPARIS The contrast is especially sharp in the way clinicians speak about renal denervation and the way companies promote this new procedure. In the language of physicians, the idea that a device-based therapy can reduce or replace drug-based ... Medical Device Daily, 1 day ago
|
Rockwell Steadies Itself For A Phase III Run-UpRockwell Medical (RMTI) is a bio-pharmaceutical company that's focused on addressing end-stage renal disease and chronic kidney disease with innovative products and services for the treatment of iron deficiency, secondary hyperparathyroidism and ... Seeking Alpha, 2 days ago
|
Prev
| Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
►AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts
rediff News App
Related Queries - continuous renal replacement therapy
Alerts
Get updated on latest news & your favorite topics right in your inbox!
Widget
Get Realtime News on your webpage & get your members hooked!
Happening by Location
Click on any location on map to view latest news by location
